Exact Mass: 280.1091
Exact Mass Matches: 280.1091
Found 200 metabolites which its exact mass value is equals to given mass value 280.1091,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Aspartylphenylalanine
Aspartylphenylalanine is a dipeptide composed of aspartate and phenylalanine, and is a metabolic byproduct of its methyl ester, aspartame (Nutrasweet). After hydrolysis of the ester bond in the intestinal lumen, the dipeptide is apparently absorbed and digested in the same manner as dipeptides derived from protein digestion. There are several Asp-Phe dipeptidases that degrade this peptide. It has been suggested that individuals with aspartame allergies may be deficient in this peptidase (PMID: 3743970). It has been observed that N-beta-aspartylphenylalanine (a breakdown product of Asp-Phe) is a naturally occurring peptide found in both blood and urine (PMID: 2723819).
Degradation product of Aspartame
Ipriflavone
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization Feed additive, catabolic agent. Feed additive, catabolic agent
Asparenyol
Asparenyol is found in green vegetables. Asparenyol is a constituent of cultured cells of asparagus (Asparagus officinalis). Constituent of cultured cells of asparagus (Asparagus officinalis). Asparenyol is found in green vegetables.
Phenylalanylaspartic acid
Phenylalanylaspartic acid is a dipeptide composed of phenylalanine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
L-beta-aspartyl-L-phenylalanine
L-beta-aspartyl-l-phenylalanine is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]
Levosimendan
Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner. It also has a vasodilatory effect, by opening adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle to cause smooth muscle relaxation. D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Phenprocoumon
Phenprocoumon is only found in individuals that have used or taken this drug. It is a coumarin derivative that acts as a long acting oral anticoagulant. [PubChem]Phenprocoumon inhibits vitamin K reductase, resulting in depletion of the reduced form of vitamin K (vitamin KH2). As vitamin K is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins, this limits the gamma-carboxylation and subsequent activation of the vitamin K-dependent coagulant proteins. The synthesis of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Depression of three of the four vitamin K-dependent coagulation factors (factors II, VII, and X) results in decreased prothrombin levels and a decrease in the amount of thrombin generated and bound to fibrin. This reduces the thrombogenicity of clots.
4-(2-Aminopyrimidin-4-yl)-6-(2-aminopyrimidin-4(3H)-ylidene)cyclohexa-2,4-dien-1-one
Flumecinol
C26170 - Protective Agent > C2081 - Hepatoprotective Agent
Simendan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Methylenedihydrotanshinquinone
2-Hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene|8-carboxy-2-hydroxy-1-methyl-5-vinyl-9,10-dihydrophenanthrene|9,10-Dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid
2-(2-methoxy-4-hydroxyphenyl)-5-(E)-propenylbenzofuran|Ratanhiaphenol III
3-(methoxycarbonyl)propyl beta-D-glucopyranoside|3-(Methoxycarbonyl)propyl-??-D-glucopyranoside
(Z)-4,4-dihydroxy-3-methoxy-1,5-diphenylpent-3-en-1-yne|lawsochylin C
(E)-2-(4-hydroxyphenyl)-7-methoxy-5-(1-propenyl)benzofuran|2-(4-hydroxyphenyl)-7-methoxy-5-(E)-propenylbenzofuran|7-Metoxy-2-(4-Hydroxyphenyl)-5-(1-propenyl)-benzofuran
2-(2-hydroxy-4-methoxyphenyl)-5-(E)-propenylbenzofuran|Ratanhiaphenol I|rataniaphenol III|ratanthiaphenol
2-(4-hydroxyphenyl)-5-(2-oxopropyl)-3-methylbenzofuran
ipriflavone
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization relative retention time with respect to 9-anthracene Carboxylic Acid is 1.328 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.329
Levosimendan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Asp-phe
A dipeptide formed from L-alpha-aspartyl and L-phenylalanine residues. It is obtained after the hydrolysis of aspartame in intestinal lumen.
Phenprocoumon
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists A hydroxycoumarin that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenylpropyl group. D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
6-hydroxy-7E,9E-Octadecadiene-11,13,15,17-tetraynoic acid
6-hydroxy-7E,9Z-Octadecadiene-11,13,15,17-tetraynoic acid
6-hydroxy-7Z,9E-Octadecadiene-11,13,15,17-tetraynoic acid
Levosimedan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Phe-asp
A dipeptide formed from L-phenylalanine and L-aspartic acid residues.
(2S,4S)-4-Boc-Amino pyrrolidine-2-carboxylic acid methylester hydrochloride
2-AMINO-4-METHOXY-7-(BETA-D-2-DEOXYRIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE
(R)-4-N-BOC-PIPERAZINE-2-CARBOXYLIC ACID METHYL ESTER-HCl
tert-Butyl 6-(aminomethyl)thieno[2,3-d]pyrimidin-4-ylcarbamate
Ethyl 3-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl) propanoate
bis(trimethylsilyl)hypoxathine
9-(Trimethylsilyl)-6-[(trimethylsilyl)oxy]-9H-purine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=17962-89-9 (retrieved 2024-09-24) (CAS RN: 17962-89-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
METHYL (2R,4S)-4-BOC-AMINOPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE
4-(2,6-Dimethylmorpholin-4-yl)-3-nitrobenzoic acid
(S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride
N-[(2,4-DIPHENYL-1,3-THIAZOL-5-YL)METHYL]-N-METHYLAMINE
N-Boc-cis-4-Amino-L-proline methyl ester hydrochloride
N-Boc-trans-4-amino-L-proline methyl ester hydrochloride
2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid hydrochloride
(E)-3-Cyclopentyl-2-(4-(methylsulfonyl)phenyl)prop-2-en-1-ol
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-2-one
1H-PYRROLO[2,3-B]PYRIDINE, 1-(METHYLSULFONYL)-4-(1-PIPERAZINYL)-
1,3-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, hydrochloride (1:1), (3S)-
6(5H)-Pteridinone, 2-chloro-8-cyclopentyl-7-ethyl-7,8-dihydro
(4,5-DIMETHYL-3-PHENYL-3H-THIAZOL-2-YLIDENE)-PHENYL-AMINE
(2R,4R)-Methyl 4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL
Rataniaphenol I
A member of the class of benzofurans that is 1-benzofuran substituted by a 2-hydroxy-4-methoxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
4H-1-Benzopyran-4-one, 6-methoxy-2-(2-phenylethyl)-
4H-1-Benzopyran-4-one, 2-(2-methoxyphenyl)-6,8-dimethyl-
(1S)-1,2,3,4-Tetrahydro-benzo[C]phenanthrene-2,3,4-triol
2-[(2-Amino-3-phenylpropanoyl)amino]butanedioic acid
(2S,3R,4S)-2-amino-3,5-dihydroxy-4-(hydroxymethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
(2S,3R,4R)-2-amino-3,5-dihydroxy-4-(hydroxymethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
Rataniaphenol III
A member of the class of benzofurans that is 1-benzofuran substituted by a 2-methoxy-4-hydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
3-Benzyl-5-tert-butyl-1,3,5-thiadiazinane-2-thione
(1S,3S,11R,11aR)-3-amino-1,7,8,11-tetrahydroxy-1,2,3,6,11,11a-hexahydro-4H-pyrido[1,2-b]isoquinolin-4-one
3-(4,7-Dimethyl-1-quinolin-1-iumyl)-1-propanesulfonic acid
3-(2,7-Dimethyl-1-quinolin-1-iumyl)-1-propanesulfonic acid
[(4R)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]methyl octanoate
2-Isopropyl-3-(4-hydroxybenzoyl)benzofuran
2-(2-(4-methoxyphenyl)ethyl)chromone
A member of the class of chromones that is chromone which is substituted by a 2-(4-methoxyphenyl)ethyl group at position 2. It is found in agarwood, a fragrant resinous heartwood from trees of the genus Aquilaria.
fumisoquin A
A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7,8 and 11R, by an amino group at position 3S and an oxo group at position 4. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.
MK-0608
MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay[1].
5-methoxy-2-[5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenol
(2r,3r,4s,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4-ethenyl-7-hydroxy-8-methyl-9,10-dihydrophenanthrene-1-carboxylic acid
(1r,2s,5r)-5-[(8r)-8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl]-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol
(2s)-2-({4-[(1-hydroxyethylidene)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)-3-methylbutanoic acid
(3s,5s)-5-[(2s,3s,4r)-2-chloro-1,3,4-trihydroxyheptyl]-3-methyloxolan-2-one
3-amino-1,7,8,11-tetrahydroxy-1h,2h,3h,6h,11h,11ah-pyrido[1,2-b]isoquinolin-4-one
1,2,15,16-tetrahydrotanshinone i
{"Ingredient_id": "HBIN000539","Ingredient_name": "1,2,15,16-tetrahydrotanshinone i","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC=C4C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21064","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-7-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene
{"Ingredient_id": "HBIN005771","Ingredient_name": "2-hydroxy-7-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1=C(C=CC2=C1CCC3=CC(=CC(=C32)C=C)C(=O)O)O","Ingredient_weight": "280.34","OB_score": "24.82961582","CAS_id": "NA","SymMap_id": "SMIT00724","TCMID_id": "9892","TCMSP_id": "MOL007919","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene
{"Ingredient_id": "HBIN005773","Ingredient_name": "2-hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1=C(C=CC2=C1CCC3=C(C=CC(=C32)C=C)C(=O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15817","TCMID_id": "9893","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-(methoxycarbonyl)propyl-β-d-glucopyra-noside
{"Ingredient_id": "HBIN008821","Ingredient_name": "3-(methoxycarbonyl)propyl-\u03b2-d-glucopyra-noside","Alias": "NA","Ingredient_formula": "C11H20O8","Ingredient_Smile": "COC(=O)CCCOC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13870","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid
{"Ingredient_id": "HBIN013941","Ingredient_name": "9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "NA","Ingredient_weight": "280.32","OB_score": "NA","CAS_id": "147850-85-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7301","PubChem_id": "NA","DrugBank_id": "NA"}
9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-2-phenanthrenecarboxylic acid
{"Ingredient_id": "HBIN013942","Ingredient_name": "9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-2-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "NA","Ingredient_weight": "280.32","OB_score": "NA","CAS_id": "144106-82-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7300","PubChem_id": "NA","DrugBank_id": "NA"}
